Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy

Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy

US Patent 11730150 · Granted Aug 22, 2023

Estimated economic value: $115,236,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Mouse model of DITRA disease and uses thereof2025
Methods for modifying a genome2025
Non-human animals expressing humanized CD3 complex2025
Humanized IL-15 animals2025
Nucleic acids encoding anchor modified antibodies and uses thereof2025
Nucleic acids encoding anchor modified antibodies and uses thereof2025
Methods of treatment using a leptin receptor agonist antibody2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
Methods for producing antigen-binding proteins against foreign antigens2025
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing 2025
Methods for treating patients with hyperlipidemia by administering a PCSK9 inhib2025